Ipamorelin 2mg/vial For Bodybuilding CAS:170851-70-4
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS), specifically targeting ghrelin receptors to stimulate the pituitary gland’s release of growth hormone (GH).
Introduction to Ipamorelin
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS), specifically targeting ghrelin receptors to stimulate the pituitary gland's release of growth hormone (GH). Unlike earlier peptides like GHRP-6 or GHRP-2, Ipamorelin is highly selective, minimizing off-target effects such as cortisol or prolactin spikes. This specificity makes it a favored choice among bodybuilders seeking lean muscle gains without unwanted side effects.
Key Features of Ipamorelin
●Selective Action: Binds exclusively to ghrelin receptors in the pituitary, avoiding activation of adrenal or prolactin pathways.
●Extended Half-Life: Approximately 2 hours, allowing for sustained GH pulses without frequent dosing.
●Non-Hunger Inducing: Unlike GHRP-6, it doesn't stimulate appetite, making it ideal for cutting phases.
●Stability: Resistant to enzymatic degradation, enhancing bioavailability via subcutaneous injection.
●Safety Profile: Low incidence of side effects, validated in clinical trials for postoperative ileus, indicating its therapeutic potential.
Applications in Bodybuilding
1.Muscle Hypertrophy: Enhances protein synthesis and nitrogen retention, promoting lean mass.
2.Fat Metabolism: Increases lipolysis, particularly in stubborn areas like the abdomen.
3.Recovery Acceleration: Reduces muscle soreness and repair time through IGF-1 upregulation.
4.Joint and Tendon Health: Boosts collagen synthesis, mitigating injury risks during heavy lifting.
5.Anti-Aging Benefits: Improves skin elasticity and bone density, ancillary perks for physique athletes.
Benefits Over Alternatives
●Precision: Targets GH release without disrupting other hormones.
●Convenience: Twice-daily dosing suffices due to longer half-life compared to GHRP-2.
●Tolerance Management: Lower risk of receptor desensitization, permitting longer cycles.
●Sleep Quality: Evening doses amplify slow-wave sleep, optimizing recovery.
Dosage Protocols
●Beginners: 100–200 mcg once daily, preferably post-workout or pre-bedtime.
●Advanced Users: 300–500 mcg split into two doses (morning and evening).
●Stacking: Often paired with CJC-1295 (a GHRH analog) to amplify GH pulsatility.
Cycle Recommendations
●Duration: 8–12 weeks, followed by a 4–6 week hiatus to restore pituitary sensitivity.
●Pulsatile Dosing: Mimicking natural GH surges, users inject 1–2 hours post-fasting or post-exercise.
Half-Life and Timing
With a 2-hour half-life, Ipamorelin's effects peak within 30–60 minutes. To mimic the body's natural GH rhythm (e.g., nocturnal surges), evening administration is critical. Users report synergistic effects when timed with resistance training or intermittent fasting.
Post-Cycle Considerations (PTC)
While traditional post-cycle therapy (PCT) isn't required (as Ipamorelin doesn't suppress testosterone), a structured off-period is advised:
●Natural GH Restoration: A 4-week break post-cycle helps prevent receptor downregulation.
●Supportive Supplements: Melatonin, L-arginine, and GABA may bolster endogenous GH during off-cycles.
Safety and Side Effects
●Common: Mild injection-site erythema or transient headaches.
●Rare: Joint stiffness or carpal tunnel symptoms at supra-physiological doses.
●Contraindications: Avoid with diabetes mellitus due to potential glucose modulation.
Legal and Ethical Considerations
Ipamorelin is unapproved by the FDA for human use and classified as a research chemical. Athletes should verify anti-doping regulations, as WADA prohibits GH secretagogues.
User Experiences and Anecdotal Evidence
●Bulking Phase: Users report 4–6 lbs of lean mass over 12 weeks when combined with resistance training.
●Cutting Phase: Enhanced vascularity and reduced subcutaneous fat within 8 weeks.
●Injury Recovery: Faster tendon repair noted in logs, attributed to elevated IGF-1.
Scientific Backing
A 2001 study in European Journal of Endocrinology demonstrated Ipamorelin's GH-releasing efficacy without affecting ACTH or cortisol. Another trial in Journal of Clinical Pharmacology (2008) highlighted its gastrointestinal applications, underscoring its safety.
Clinical Data
|
Trade names |
INN, ipamorelin |
|
CAS |
170851-70-4 |
|
Molar mass |
711.868 |
|
MF |
C38H49N9O5 |
|
Purity |
Above 98% |
|
Apprarance |
2mg/vial,Lyophilized powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Ipamorelin offers a refined approach to GH enhancement, balancing efficacy with tolerability. Its selective mechanism, coupled with practical dosing, positions it as a versatile tool for bodybuilders prioritizing quality gains and metabolic health. However, users must navigate legal ambiguities and prioritize cycle management to sustain long-term benefits.
Hot Tags: ipamorelin 2mg/vial for bodybuilding cas:170851-70-4, China ipamorelin 2mg/vial for bodybuilding cas:170851-70-4 manufacturers, suppliers, factory
